benzyl 2-amino-3-(3,4,5-trimethoxybenzoyl)-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-carboxylate

ID: ALA523396

PubChem CID: 44580425

Max Phase: Preclinical

Molecular Formula: C25H26N2O6S

Molecular Weight: 482.56

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(C(=O)c2c(N)sc3c2CCN(C(=O)OCc2ccccc2)C3)cc(OC)c1OC

Standard InChI:  InChI=1S/C25H26N2O6S/c1-30-18-11-16(12-19(31-2)23(18)32-3)22(28)21-17-9-10-27(13-20(17)34-24(21)26)25(29)33-14-15-7-5-4-6-8-15/h4-8,11-12H,9-10,13-14,26H2,1-3H3

Standard InChI Key:  MWLYDGLECFVMIT-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
    7.7896  -17.9970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9623  -18.0052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5574  -18.7246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9789  -19.4365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8093  -19.4243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2104  -18.7042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1939  -17.2778    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5422  -17.2950    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7324  -18.7337    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3120  -18.0238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7173  -17.3036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0189  -17.2683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2325  -20.1325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8308  -20.8531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0575  -20.1200    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5736  -22.1620    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.1782  -21.6008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8528  -21.7603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0144  -20.9490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3959  -20.4064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6124  -20.6699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4509  -21.4813    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0729  -22.0291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9878  -21.7597    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6693  -21.7456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0496  -21.2010    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5074  -22.5547    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2115  -20.3919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5930  -19.8476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7536  -19.0382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1337  -18.4964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3530  -18.7627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1956  -19.5761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8168  -20.1143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 18 16  1  0
 16 17  1  0
 17 14  2  0
 18 19  2  0
  3  9  1  0
  4  5  1  0
  9 10  1  0
  2  3  1  0
  8 11  1  0
 18 23  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
  5  6  2  0
 17 24  1  0
  7 12  1  0
 22 25  1  0
  6  1  1  0
 25 26  1  0
  5 13  1  0
 25 27  2  0
  1  2  2  0
 26 28  1  0
 28 29  1  0
 13 14  1  0
  1  7  1  0
 29 30  2  0
 13 15  2  0
 30 31  1  0
 14 19  1  0
 31 32  2  0
  3  4  2  0
 32 33  1  0
  2  8  1  0
 33 34  2  0
 34 29  1  0
M  END

Associated Targets(Human)

CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

FM3A (1296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 482.56Molecular Weight (Monoisotopic): 482.1512AlogP: 4.28#Rotatable Bonds: 7
Polar Surface Area: 100.32Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.41CX LogD: 4.41
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.50Np Likeness Score: -0.76

References

1. Romagnoli R, Baraldi PG, Carrion MD, Cruz-Lopez O, Cara CL, Tolomeo M, Grimaudo S, Di Cristina A, Pipitone MR, Balzarini J, Kandil S, Brancale A, Sarkar T, Hamel E..  (2008)  Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-6-substituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine derivatives as antimitotic agents and inhibitors of tubulin polymerization.,  18  (18): [PMID:18725179] [10.1016/j.bmcl.2008.08.006]

Source